This HTML5 document contains 131 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
n15http://caligraph.org/resource/Victor_V.
n22http://caligraph.org/resource/Ellen_J.
n20http://en.wikipedia.org/wiki/Frank_J.
n10http://caligraph.org/ontology/S&
n9http://caligraph.org/resource/Thousand_Oaks,
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n4http://en.wikipedia.org/wiki/Category:
n5http://en.wikipedia.org/wiki/S&
n23http://en.wikipedia.org/wiki/Category:Companies_based_in_Thousand_Oaks,
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n24http://en.wikipedia.org/wiki/List_of_S&
owlhttp://www.w3.org/2002/07/owl#
n12http://caligraph.org/resource/David_W.
n16http://caligraph.org/resource/Robert_A.
n17http://caligraph.org/resource/Roger_M.
clgohttp://caligraph.org/ontology/
n21http://caligraph.org/ontology/Company_based_in_Thousand_Oaks,
n8http://en.wikipedia.org/wiki/
provhttp://www.w3.org/ns/prov#
n11http://en.wikipedia.org/wiki/Thousand_Oaks,
xsdhhttp://www.w3.org/2001/XMLSchema#
n18http://caligraph.org/resource/President_(corporate_title)
dbrhttp://dbpedia.org/resource/
clgrhttp://caligraph.org/resource/
Subject Item
n17:_Perlmutter
clgo:knownFor
clgr:Amgen
Subject Item
n15:_Solovyev
clgo:institution
clgr:Amgen
Subject Item
clgr:Josef_Penninger
clgo:institution
clgr:Amgen
Subject Item
clgr:Onyx_Pharmaceuticals
clgo:parentCompany
clgr:Amgen
Subject Item
clgr:Amgen
rdf:type
clgo:Orphan_drug_company clgo:Largest_civil_only_pharmaceutical_settlement n10:P_500_company clgo:Person clgo:Biopharmaceutical_company clgo:Political_action_committee clgo:Company_in_the_Dow_Jones_Industrial_Average clgo:Biotechnology_company_established_in_1980 owl:NamedIndividual clgo:Corporation_based_in_Mississauga clgo:Company_listed_on_the_Nasdaq clgo:1980_establishment_in_California clgo:Multinational_company_headquartered_in_the_United_States clgo:Pharmaceutical_manufacturer_in_the_United_Kingdom clgo:Manufacturing_company clgo:Pharmaceutical_company_of_the_United_States clgo:California_company clgo:1980s_initial_public_offering n21:_California clgo:Pharmaceutical_company_established_in_1980 clgo:Largest_pharmaceutical_settlement clgo:Biotechnology_company_of_the_United_States
rdfs:label
Amgen
owl:sameAs
dbr:Amgen
prov:wasDerivedFrom
n4:Orphan_drug_companies n5:P_100 n8:Dow_Jones_Composite_Average n8:Thurgood_Marshall_College_Fund n8:Verband_Forschender_Arzneimittelhersteller n4:Companies_listed_on_the_Nasdaq n11:_California n8:Cambridge_Science_Park n8:Amgen n8:List_of_California_companies n4:Multinational_companies_headquartered_in_the_United_States n8:Tech_Council_of_Maryland n8:Corporate_tax_in_the_United_States n8:List_of_pharmaceutical_companies n8:Leaders_for_Global_Operations n8:List_of_largest_biomedical_companies_by_revenue n8:Pharmaceutical_industry_in_India n4:1980_establishments_in_California n8:List_of_largest_biomedical_companies_by_market_capitalization n8:List_of_political_action_committees n8:Medication_costs n4:1980s_initial_public_offerings n8:Pharmaceutical_industry n8:Dow_Jones_Global_Titans_50 n8:Historical_components_of_the_Dow_Jones_Industrial_Average n8:List_of_corporations_based_in_Mississauga n8:List_of_pharmaceutical_manufacturers_in_the_United_Kingdom n8:List_of_largest_civil_only_pharmaceutical_settlements n4:Pharmaceutical_companies_established_in_1980 n4:Pharmaceutical_companies_of_the_United_States n8:The_Global_Dow n8:Pharmaceutical_industry_in_Switzerland n8:Companies_of_the_United_States_with_untaxed_profits n8:Russell_1000_Index n8:Cost_of_drug_development n8:List_of_companies_by_research_and_development_spending n8:Robert_Provenzano n4:Biotechnology_companies_of_the_United_States n8:Nasdaq-100 n8:Pharmaceutical_industry_in_the_United_Kingdom n20:_Aquila n8:Rely_on_Your_Beliefs_Fund n8:National_Medal_of_Technology_and_Innovation n8:Biomedical_research_in_the_United_States n8:21st_Century_Cures_Act n8:List_of_largest_pharmaceutical_settlements n4:Companies_in_the_Dow_Jones_Industrial_Average n8:Biotechnology_industry_in_Boston n23:_California n4:Biotechnology_companies_established_in_1980 n4:Biopharmaceutical_companies n24:P_500_companies
skos:prefLabel
Amgen
skos:altLabel
AMGEN Amgen Inc. Amgen#NASDAQ Amgen, Inc. Immunex Amgen Canada Amgen Inc Amgen Inc.’s AmGen, Inc. PAC AMGen
clgo:assets
6.117E10
clgo:equity
6.7E9
clgo:foundingDate
1980-04-08
clgo:foundingYear
1980
clgo:industry
clgr:Technology clgr:Health_care clgr:Biotechnology clgr:Medication clgr:Biopharmaceutical
clgo:keyPerson
clgr:Chairperson n16:_Bradway n18:
clgo:location
n9:_California clgr:United_States
clgo:netIncome
5.89E9
clgo:numberOfEmployees
2021
clgo:operatingIncome
7.64E9
clgo:product
clgr:Evolocumab clgr:Romiplostim clgr:Etelcalcetide clgr:Darbepoetin_alfa clgr:Anakinra clgr:Panitumumab clgr:Carfilzomib clgr:Denosumab clgr:Epoetin_alfa clgr:Filgrastim clgr:Blinatumomab clgr:Etanercept clgr:Cinacalcet clgr:Erenumab clgr:Pegfilgrastim
clgo:revenue
25.98
clgo:type
clgr:Public_company
Subject Item
clgr:Nicholas_Lydon
clgo:institution
clgr:Amgen
Subject Item
n16:_Bradway
clgo:occupation
clgr:Amgen
Subject Item
clgr:David_Siderovski
clgo:institution
clgr:Amgen
Subject Item
n22:_Kullman
clgo:board
clgr:Amgen
Subject Item
clgr:DeCODE_genetics
clgo:parentCompany
clgr:Amgen
Subject Item
n12:_Wood
clgo:institution
clgr:Amgen